Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On August 9, 2024, FSD Pharma, Inc. (the “Company”) issued a press release (“Press Release”) announcing a share consolidation, name change and other matters , which are described in more detail in Exhibit 99.1 attached hereto and incorporated herein by reference. The Press Release is incorporated by reference into the Company’s Registration Statement on Form F-3, (File No. 333-276264), as amended or supplemented, to the extent not superseded by documents or reports subsequently filed or amended.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
